Controversies in the management of the critically ill: the role of probiotics - PubMed (original) (raw)
Review
Controversies in the management of the critically ill: the role of probiotics
Maria Theodorakopoulou et al. Int J Antimicrob Agents. 2013 Jun.
Abstract
Probiotics are commercially available, viable, non-pathogenic micro-organisms that, when ingested in sufficient quantities, exert a health benefit to the host derived through modification of the gut flora, local release of antimicrobial factors, maintenance of integrity of the gut barrier, competition for epithelial adherence, prevention of bacterial translocation, and modulation of the local immune response. In critically ill patients, probiotics appear to lead to decreased susceptibility to antibiotic-associated diarrhoea, Clostridium difficile infections, ventilator-associated pneumonia, necrotising enterocolitis, acute severe pancreatitis, sepsis and multiple organ dysfunction syndrome as well as a shortened duration of infections. Current scientific evidence supporting the use of probiotics is not conclusive and is mainly derived from single-centre, not very well designed trials that are limited by many factors including small sample sizes, heterogeneity in the probiotic strains used, effectiveness of the combined strains, optimum dose regimens, frequency and duration of administration, and certainly incomplete knowledge of the mechanism of action of each strain. Probiotics appear to be well tolerated, whilst adverse events are very rare. The most commonly reported adverse events include bacteraemia, fungaemia and sepsis. At present, based on the available evidence and although helpful and relatively safe for certain disease conditions, routine use of probiotics in the critically ill is not recommended.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Similar articles
- Probiotics in the intensive care unit.
Morrow LE, Gogineni V, Malesker MA. Morrow LE, et al. Nutr Clin Pract. 2012 Apr;27(2):235-41. doi: 10.1177/0884533612440290. Nutr Clin Pract. 2012. PMID: 22473797 Review. - Probiotic, prebiotic, and synbiotic use in critically ill patients.
Morrow LE, Gogineni V, Malesker MA. Morrow LE, et al. Curr Opin Crit Care. 2012 Apr;18(2):186-91. doi: 10.1097/MCC.0b013e3283514b17. Curr Opin Crit Care. 2012. PMID: 22343306 Review. - Probiotics for infectious diseases: more drugs, less dietary supplementation.
Kotzampassi K, Giamarellos-Bourboulis EJ. Kotzampassi K, et al. Int J Antimicrob Agents. 2012 Oct;40(4):288-96. doi: 10.1016/j.ijantimicag.2012.06.006. Epub 2012 Aug 2. Int J Antimicrob Agents. 2012. PMID: 22858373 Review. - Probiotics in critically ill children.
Singhi SC, Kumar S. Singhi SC, et al. F1000Res. 2016 Mar 29;5:F1000 Faculty Rev-407. doi: 10.12688/f1000research.7630.1. eCollection 2016. F1000Res. 2016. PMID: 27081478 Free PMC article. Review. - Synbiotics and probiotics in the critically ill after the PROPATRIA trial.
Morrow LE, Gogineni V, Malesker MA. Morrow LE, et al. Curr Opin Clin Nutr Metab Care. 2012 Mar;15(2):147-50. doi: 10.1097/MCO.0b013e32834fcea8. Curr Opin Clin Nutr Metab Care. 2012. PMID: 22248590 Review.
Cited by
- The role of bacterial translocation in sepsis: a new target for therapy.
Potruch A, Schwartz A, Ilan Y. Potruch A, et al. Therap Adv Gastroenterol. 2022 May 9;15:17562848221094214. doi: 10.1177/17562848221094214. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35574428 Free PMC article. Review. - Probiotics: Should We Use Them Proactively in Critical Illness?
Soni KD. Soni KD. Indian J Crit Care Med. 2022 Mar;26(3):266-267. doi: 10.5005/jp-journals-10071-24174. Indian J Crit Care Med. 2022. PMID: 35519925 Free PMC article. - Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients.
Yelin I, Flett KB, Merakou C, Mehrotra P, Stam J, Snesrud E, Hinkle M, Lesho E, McGann P, McAdam AJ, Sandora TJ, Kishony R, Priebe GP. Yelin I, et al. Nat Med. 2019 Nov;25(11):1728-1732. doi: 10.1038/s41591-019-0626-9. Epub 2019 Nov 7. Nat Med. 2019. PMID: 31700189 Free PMC article. - Synbiotics for prevention of ventilator-associated pneumonia: a probiotics strain-specific network meta-analysis.
Fan QL, Yu XM, Liu QX, Yang W, Chang Q, Zhang YP. Fan QL, et al. J Int Med Res. 2019 Nov;47(11):5349-5374. doi: 10.1177/0300060519876753. Epub 2019 Oct 3. J Int Med Res. 2019. PMID: 31578896 Free PMC article. - Probiotics for Preventing Ventilator-Associated Pneumonia in Mechanically Ventilated Patients: A Meta-Analysis with Trial Sequential Analysis.
Weng H, Li JG, Mao Z, Feng Y, Wang CY, Ren XQ, Zeng XT. Weng H, et al. Front Pharmacol. 2017 Oct 9;8:717. doi: 10.3389/fphar.2017.00717. eCollection 2017. Front Pharmacol. 2017. PMID: 29062279 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources